コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
4 nced gene expression of the peptidylarginine deiminase 2 gene, itself a chromatin-modifying protein.
5 expression and activity of peptidylarginine deiminase 2, one of the five enzymes responsible for cit
8 dotoxic mice with YW3-56, a peptidylarginine deiminase-2/4 inhibitor, significantly diminished levels
9 d in the three genes PADI3 (peptidylarginine deiminase 3), TGM3 (transglutaminase 3), and TCHH (trich
10 ied citrullination sites in protein arginine deiminase 4 (12 sites) and in fibrinogen (25 sites, two
11 ulline with recombinant polypeptide arginine deiminase 4 (PAD4) abolished ADAMDEC1-catalyzed pro-EGF1
12 n NET formation, including peptidyl arginine deiminase 4 (PAD4) activity, neutrophil nuclear histone
13 ination of core histones by peptidylarginine deiminase 4 (PAD4) and that patients with autoimmune dis
14 citrullination catalyzed by peptidylarginine deiminase 4 (PAD4) correlates with chromatin decondensat
15 sumed role of an overactive protein arginine deiminase 4 (PAD4) in the pathophysiology of rheumatoid
20 rullination of histones by peptidyl arginine deiminase 4 (PAD4) is central for NET formation in vivo.
22 , we demonstrate that human peptidylarginine deiminase 4 (PAD4) regulates histone Arg methylation by
23 t of specific inhibitors of protein-arginine deiminase 4 (PAD4), an enzyme required for NET formation
24 [NETosis]), orchestrated by peptidylarginine deiminase 4 (PAD4), damages organs in acute inflammatory
26 hils express high levels of peptidylarginine deiminase 4 (PAD4), which catalyzes histone citrullinati
27 analyzed venous thrombi in peptidylarginine deiminase 4 (PAD4)-deficient mice that cannot citrullina
30 functional haplotype of the peptidylarginine deiminase 4 gene (PADI4) has recently been identified as
33 enzyme initiating NETosis, peptidylarginine deiminase 4, and activates the NOD-like receptor family,
34 tion mark of p300 GBD is removed by peptidyl deiminase 4, thereby enhancing the p300-GRIP1 interactio
37 histone citrullination by peptidyl arginine deiminase-4 (PADI4) in contact to particulate agents to
38 s via DNase infusion, or in peptidylarginine deiminase-4-deficient mice (which have impaired NET prod
41 termined that strain 1457 devoid of arginine deiminase activity (1457 DeltaADI) was significantly les
42 ant Manfredo strains for the enzyme arginine deiminase (AD) showed that significant activity was pres
47 o evaluate the effects of pegylated arginine deiminase (ADI) in terms of toxicity, tumor response, al
49 on the use of recombinant bacterial arginine deiminase (ADI) isolated from the cells of a recombinant
50 rcA2) to assess the function of the arginine deiminase (ADI) pathway in organic acid resistance and b
51 of the amino acid arginine via the arginine deiminase (ADI) pathway supplements energy production an
52 le to therapeutic intervention with arginine deiminase (ADI), an enzyme responsible for consuming the
53 rginine deprivation using pegylated arginine deiminase (ADI-PEG 20) against primary AMLs in a xenogra
57 e arginine-lowering agent pegylated arginine deiminase (ADI-PEG20) has not been evaluated in a random
59 ding recombinant protein, pegylated arginine deiminase (ADI-PEG20), has been in clinical trials for t
64 ing ornithine carbamoyltransferase, arginine deiminase, alpha-enolase, and alpha- and beta-giardins,
67 se 2 randomized clinical trial, the Arginine Deiminase and Mesothelioma (ADAM) study, was conducted b
68 s of polyamine biosynthetic enzymes agmatine deiminase and N-carbamoylputrescine amidohydrolase in ar
69 e anr gene (anaerobic regulation of arginine deiminase and nitrate reduction) that controls anaerobic
70 or acetaldehyde dehydrogenase ExaC, arginine deiminase ArcA, and glyceraldehyde 3-phosphate dehydroge
71 s and P. gingivalis, and identified arginine deiminase (ArcA) of S. cristatus as the signaling molecu
72 erived from Streptococcus cristatus arginine deiminase (ArcA) was able to repress the expression and
73 ent mutants were constructed within arginine deiminase (arcA1 and arcA2) to assess the function of th
74 wo coupled recognition modules, a creatinine deiminase (CD) enzyme and a 2-nitrophenol (2NPh) titrati
75 protein cross-linking) and peptidyl-arginine deiminase (conversion of arginines to citrullines with l
77 he citrulline formed by the peptidylarginine deiminase enzyme modification functions to unfold protei
78 y (t(1/2)=4.8h) whereas a bacterial arginine deiminase evaluated in phase II clinical trials was repo
81 ial kinetic characterization of the agmatine deiminase from Helicobacter pylori and described the syn
83 film assays of mutants of all three agmatine deiminase genes in PA14 revealed that deletion of agu2AB
85 biofilm growth and the function of arginine deiminase in USA300 clones led us to genetically inactiv
89 tion network and identified peptidylarginine deiminases, kallikreins, serine proteinase inhibitor fam
92 lly inactivate the sole copy of the arginine deiminase operon by deleting the arginine/ornithine anti
93 n P. aeruginosa GMSF enzymes PaADI, agmatine deiminase (PaAgDI), and N(omega),N(omega)-dimethylargini
94 on of H3R26 is catalyzed by peptidylarginine deiminase (PAD) 2 and not by PAD4 (which citrullinates H
96 d was PAD3, a member of the peptidylarginine deiminase (PAD) enzyme family that converts protein argi
98 protein or influencing the peptidylarginine deiminase (PAD) enzymes found in the monocyte/macrophage
101 ly found that Cl-amidine, a peptidylarginine deiminase (PAD) inhibitor, improves survival in a mouse
102 vivo, LL-37 is exposed to peptidyl arginine deiminase (PAD), an enzyme released by inflammatory cell
104 o histone citrullination by protein arginine deiminase (PAD)4, exocytosis of chromatin and enzymes as
105 se (DDAH); EC 3.5.3.18] and peptidylarginine deiminase (PAD; EC 3.5.3.15) catalyze hydrolysis of subs
106 Cl-amidine, an inhibitor of peptidylarginine deiminases (PAD), to block NET formation and were evalua
108 arginine to citrulline by peptidyl arginine deiminase (PAD4), change protein structure and function.
110 c vertebrate enzymes called peptidylarginine deiminases (PADIs) and is associated with the developmen
115 rains lacking the bacterial peptidylarginine deiminases (PADs) or gingipains were created to assess t
116 ated via the actions of the protein arginine deiminases (PADs), are known to develop in the murine co
117 he reaction is catalyzed by peptidylarginine deiminases (PADs), which are found in vertebrates but no
119 ATL included those involved in the arginine deiminase pathway and a total of 140 carbohydrate transp
120 ile genetic element that encodes an arginine deiminase pathway and an oligopeptide permease system th
121 e in the expression of genes in the arginine deiminase pathway during stringent response activation.
124 of Porphyromonas gingivalis peptidylarginine deiminase (PPAD) can influence citrullination of protein
126 Padi family, encoding the peptidyl arginine deiminases responsible for citrulline protein modificati
127 metabolism by oral bacteria via the arginine deiminase system (ADS) increases the local pH, which can
131 occus mutans expresses a functional agmatine deiminase system (AgDS) encoded by the agmatine-inducibl
132 An operon encoding enzymes of the agmatine deiminase system (AgDS) has been identified in the cario
134 that the constitutive ACME-encoded arginine-deiminase system (Arc) allows USA300 to thrive in acidic
137 he citrullinating enzymes, peptidyl arginine deiminase type 4 (PAD-4), is genetically associated with
139 plets is first modified by peptidyl-arginine deiminase which denatures it and makes it more soluble.
140 termed PPAD (Porphyromonas peptidylarginine deiminase), which is genetically unrelated to eukaryotic
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。